Dulaglutide completely restored sperm quality, DNA integrity, and testicular function in obese mice without harming healthy reproductive tissue.
All parameters restoredDulaglutide returned every measured testicular function marker to normal levels in obese mice within 5 weeks
What the researchers found
Dulaglutide (a GLP-1 receptor agonist) completely restored testicular function in obese mice to normal levels. Obese mice had lower testes-to-body weight ratios, increased sperm DNA damage, chromosomal abnormalities, reduced sperm count and motility, more morphological defects, and disrupted testicular redox balance. Five weeks of dulaglutide treatment reversed all of these parameters back to control levels.
Importantly, dulaglutide showed no harmful effects on testicular cells when given to healthy, non-obese mice, suggesting safety for reproductive function.
Why it matters
Obesity is a known cause of male infertility, and millions of men are now taking GLP-1 drugs for weight loss. This study addresses a critical safety and potential benefit question: not only does dulaglutide appear safe for male reproductive function, it may actually reverse the testicular damage caused by obesity itself.
The numbers in context
0.6 mg/kg/day dulaglutide · 12-week high-fat diet · 5 weeks treatment · All parameters restored to control levels · No harm in healthy mice
How the study worked
Mouse study using a high-fat diet-induced obesity model. After 12 weeks on a high-fat diet, obese mice were randomized to receive dulaglutide (0.6 mg/kg/day) or saline for 5 weeks. Healthy mice also received dulaglutide as a safety control. Testes and sperm were collected 24 hours after the last injection. Outcomes included sperm DNA damage (comet assay), chromosomal abnormalities at diakinesis-metaphase I, spermiogram analysis (count, motility, morphology), and testicular redox balance markers.
Who was studied
Male mice on high-fat diet-induced obesity model (number per group not specified in abstract)
What this study cannot tell us
This is a mouse study, and reproductive physiology differs significantly between mice and humans. The dulaglutide dose (0.6 mg/kg/day) is much higher relative to body weight than typical human doses. The 5-week treatment period covers roughly one mouse spermatogenesis cycle but may not reflect long-term effects. Human clinical data on GLP-1 drugs and male fertility are still needed.
How to read the evidence
This is an animal study in mice, which provides important mechanistic and safety data but cannot be directly extrapolated to human reproductive outcomes. The comprehensive assessment of multiple testicular endpoints strengthens the findings within the preclinical context.
When this study was published
Published in 2024, this study addresses a timely concern as GLP-1 drug use for weight management has surged among younger, reproductively active populations.
The bigger picture
With millions of men now using GLP-1 receptor agonists for weight management, understanding their effects on male fertility is increasingly urgent. This study provides reassuring preclinical evidence that these drugs may not only be safe for male reproductive function but could actively reverse obesity-related fertility damage — a potential additional benefit that warrants human clinical investigation.
Questions still open
- Do GLP-1 drugs improve sperm quality in obese men, as they do in this mouse model?
- Are the testicular benefits due to weight loss, direct GLP-1 receptor effects on the testes, or reduced inflammation?
- How do different GLP-1 drugs (semaglutide, tirzepatide) compare in their effects on male reproductive function?
Common questions
Can GLP-1 drugs like dulaglutide affect male fertility?
Does obesity damage sperm quality?
Read the original research
Dulaglutide rescues the elevated testicular dysfunction in a mouse model of high-fat diet-induced obesity.
Mutation research. Genetic toxicology and environmental mutagenesis, 898, 503805
Citation
Attia, Sabry M; Alshamrani, Ali A; Ahmad, Sheikh F; Albekairi, Norah A; Nadeem, Ahmed; Attia, Mohamed S M; Ansari, Mushtaq A; Alqahtani, Faleh; Bakheet, Saleh A; Harisa, Gamaleldin I. (2024). Dulaglutide rescues the elevated testicular dysfunction in a mouse model of high-fat diet-induced obesity.. Mutation research. Genetic toxicology and environmental mutagenesis, 898, 503805. https://doi.org/10.1016/j.mrgentox.2024.503805